<DOC>
	<DOCNO>NCT02660424</DOCNO>
	<brief_summary>The Primary objective study evaluate efficacy VX-150 treatment osteoarthritis pain</brief_summary>
	<brief_title>A Study Efficacy Safety VX-150 Subjects With Osteoarthritis Knee</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis , Knee</mesh_term>
	<criteria>Willing able comply schedule visit , treatment plan , study restriction , laboratory test , contraceptive guideline , study procedure . Subjects ( male female [ nonchildbearing potential ] ) age 40 80 year , inclusive . Female subject must negative pregnancy test Screening Day 1 Treatment Period must nursing ; male subject must female partner pregnant nursing . Body mass index ( BMI ) 18.0 38.0 kg/m2 , inclusive , total body weight 50 150 kg . Ambulatory osteoarthritis knee symptom least 6 month pain majority day past 30 day . Symptoms must include knee joint pain . In subject bilateral knee osteoarthritis , symptomatic knee consider index knee . Radiographic evidence least one tibiofemoral osteophyte index knee within 12 month Day 1 Visit . WOMAC pain subscale score History past 10 year reactive arthritis , rheumatoid arthritis , psoriatic arthritis , ankylose spondylitis , arthritis associate inflammatory bowel disease , sarcoidosis , amyloidosis fibromyalgia . History past 10 year malignancy exception resect basal cell carcinoma , squamous cell carcinoma skin resect cervical atypia carcinoma situ . History cardiac dysrhythmias require antiarrythmia treatment ( ) . History abnormal laboratory result ≥2.5 × upper limit normal ( ULN ) indicative significant medical disease opinion investigator would preclude subject participation study . A know clinically suspected infection human immunodeficiency virus hepatitis B C virus . Other serious , acute chronic medical psychiatric illness judgment investigator could compromise subject safety , limit subject 's ability complete study and/or compromise objective study . Either participate within 3 month another investigational study subject expose study drug vaccine , participate concurrently study . History drug alcohol dependence past 3 year , positive test drug abuse Screening Visit . Requires opioids pain relief . Changed analgesic treatment regimen within 30 day Screening Visit . Received plan receive short act hyaluronic acid , corticosteroid , intraarticular injection follow : 1. index knee within 3 month Screening Visit , time study 2. joint within 4 week Screening Visit , time study Received plan receive long act hyaluronic acid intraarticular injection follow : 1. index knee within 6 month Screening Visit , time study 2. joint within 4 week Screening Visit , time study History arthroscopic open surgery within 12 month Screening Visit , plan surgery , immediately , study followup . History joint replacement surgery index knee . Significant hip pain , ipsilateral index knee may interfere assessment index knee pain . Clinical sign symptom active knee infection . Current use handicap assistance device ( unilateral assistance device cane permit ) . Started new physical therapy , weight loss , exercise program within 3 month Screening Visit , willing maintain stable program course study . Lab abnormalities screen visit .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>